A prospective registry of the MammaPrint 70 gene profile test in women with breast cancer

A registry study of women with breast cancer who have had an intermediate risk Oncotype DX score. MammaPrint is a 70 gene assay test which classifies patients as low risk or high risk for reoccurrence of cancer. This test will help guide the patient and physician with treatment decisions. Test is free of charge.

Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.